Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Peter Forsyth

15PUBLICATIONS

89CO-AUTHORS

Counselling, wellbeing and community servicesImmunogenetics (incl. genetic immunology)Mining, energy and natural resources lawHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|Mar 09, 2026

The CARING intervention for neuro-oncology family caregivers: Primary outcomes from an abbreviated randomized controlled trial.

Maija Reblin, Steven K Sutton, Hyojin Choi

|Jan 22, 2026

IGF2 supports glioblastoma growth and immune evasion through a combination of tumor cell-intrinsic and -extrinsic mechanisms.

Kyle M Heemskerk, Samir Assaf, Xiaoguang Hao

|Dec 01, 2025

STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

Howard Colman, Giuseppe Lombardi, Eric T Wong

|Oct 13, 2025

The CARING intervention for neuro-oncology family caregivers: Randomized controlled trial feasibility, eSNAP/caregiver navigation engagement, and acceptability.

Hyojin Choi, Steven K Sutton, Deanna Witte

|Sep 01, 2025

Phase IB study of Avelumab and whole brain radiotherapy in patients with leptomeningeal disease from solid tumors: Results and molecular analyses.

Yolanda Piña, Vincent Law, Solmaz Sahebjam

|May 07, 2025

Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy.

Sepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem

Pageof 3

Frequent Collaborators

5 joint publications

Inna Smalley

4 joint publications

Michael A Davies

4 joint publications

Isabella C Glitza Oliva

4 joint publications

Keiran S M Smalley

3 joint publications

Priya Kumthekar

2 joint publications

Dieta Brandsma

2 joint publications

Emilie Le Rhun

2 joint publications

Patrick Y Wen

2 joint publications

Sherise Ferguson

2 joint publications

Robert Macaulay

Frequent Collaborators

5 joint publications

Inna Smalley

4 joint publications

Michael A Davies

4 joint publications

Isabella C Glitza Oliva

4 joint publications

Keiran S M Smalley

Top Related Videos

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on : Jun 06, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

See more related videos

Top Related Videos

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on : Jun 06, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

See more related videos